Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Insider Profile

CORNELIUS JAMES M

Director | SEC CIK: 0001198959

Comprehensive Trading Performance Summary

The investment footprint of CORNELIUS JAMES M as disclosed via official SEC Form 4 filings provides a critical window into professional capital allocation strategies. By tracking this specific portfolio, investors can analyze how this individual moves capital across different boards and sectors. High-conviction moves by key stakeholders often serve as leading indicators for future market performance, as they reflect the intimate operational knowledge and fiduciary confidence of those closest to the company's decision-making process. Monitoring these strategic accumulation or exit patterns helps bridge the gap between institutional boardrooms and the retail investment community.

Filing Date Trade Date Ticker Company Name Industry Relationship Type Price Qty Total, $ Owned After Change, %
2015-08-24 22:32 2015-08-24 MJN N/A Other Director BUY $77.10 10,000 $771,000 23,837 +72.3%
2015-07-27 19:56 2015-07-27 MJN N/A Other Director BUY $89.03 10,000 $890,286 13,837 +260.6%
2015-02-04 00:23 2015-02-03 MJN N/A Other Director BUY $99.78 10,000 $997,758 49,422 +25.4%
2015-02-04 02:18 2015-01-30 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $60.60 50,000 $3,029,975 119,464 -29.5%
2014-10-18 00:16 2014-10-15 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $48.92 100,000 $4,892,000 169,041 -37.2%
2014-03-06 00:40 2014-03-05 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $55.82 100,000 $5,582,000 273,393 -26.8%
2014-02-05 01:00 2014-02-04 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $48.90 100,000 $4,890,000 373,393 -21.1%
2013-08-16 00:37 2013-08-15 MJN N/A Other Director BUY $75.99 10,000 $759,900 112,554 +9.8%
2013-07-30 23:34 2013-07-29 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $43.92 100,000 $4,392,000 542,383 -15.6%
2013-07-29 23:44 2013-07-29 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director OPT+S $43.81 5,000 $219,050 642,383 0.0%
2013-05-28 23:43 2013-05-28 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $47.61 100,000 $4,761,000 641,824 -13.5%
2013-05-20 23:17 2013-05-16 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director OPT+S $42.99 225,996 $9,716,110 741,824 0.0%
2013-05-09 23:19 2013-05-07 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $39.85 20,000 $796,900 761,824 -2.6%
2013-05-03 00:01 2013-05-01 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $39.76 20,000 $795,100 781,824 -2.5%
2013-04-29 23:22 2013-04-25 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $40.23 20,000 $804,600 801,824 -2.4%
2013-04-18 23:18 2013-04-16 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $40.79 20,000 $815,700 821,824 -2.4%
2013-04-12 00:13 2013-04-10 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $41.15 20,000 $823,000 841,824 -2.3%
2013-04-03 00:03 2013-04-01 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $41.34 20,000 $826,800 861,824 -2.3%
2013-03-28 23:31 2013-03-26 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $40.65 20,000 $813,000 881,218 -2.2%
2013-03-22 23:16 2013-03-20 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $39.78 20,000 $795,600 901,218 -2.2%
2013-03-14 23:26 2013-03-12 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $38.18 20,000 $763,600 921,218 -2.1%
2013-03-11 23:28 2013-03-07 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $37.54 20,000 $750,800 941,218 -2.1%
2013-02-28 00:08 2013-02-25 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $36.58 20,000 $731,500 1,061,218 -1.8%
2013-02-22 02:06 2013-02-20 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $36.77 20,000 $735,400 1,081,218 -1.8%
2013-02-14 01:09 2013-02-12 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $36.42 20,000 $728,300 1,101,218 -1.8%
2013-02-09 00:30 2013-02-06 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $36.47 20,000 $729,300 1,121,218 -1.8%
2013-01-31 00:06 2013-01-28 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $36.48 20,000 $729,600 1,141,218 -1.7%
2013-01-29 00:11 2013-01-24 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $36.05 20,000 $721,012 1,161,218 -1.7%
2013-01-19 00:40 2013-01-16 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $34.33 20,000 $686,600 1,181,218 -1.7%
2013-01-10 00:15 2013-01-07 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $33.49 20,000 $669,800 1,201,218 -1.6%
2013-01-08 00:25 2013-01-03 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $33.12 20,000 $662,400 1,221,218 -1.6%
2012-12-29 01:59 2012-12-27 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $32.06 20,000 $641,100 1,240,451 -1.6%
2012-12-22 01:56 2012-12-20 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $32.50 20,000 $650,000 1,260,451 -1.6%
2012-12-14 00:20 2012-12-11 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director OPT+S $33.21 20,000 $664,100 1,280,451 0.0%
2012-12-05 01:08 2012-12-03 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $32.66 20,000 $653,200 900,451 -2.2%
2012-11-30 00:08 2012-11-27 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $32.64 20,000 $652,700 920,451 -2.1%
2012-11-21 00:48 2012-11-19 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $31.97 20,000 $639,400 940,451 -2.1%
2012-11-16 00:18 2012-11-13 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $31.85 20,000 $636,900 960,451 -2.0%
2012-11-07 01:15 2012-11-05 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $33.19 20,000 $663,800 980,451 -2.0%
2012-11-01 16:19 2012-10-31 MJN N/A Other Director BUY $61.75 10,000 $617,515 98,592 +11.3%
2012-10-24 23:18 2012-10-22 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $33.54 20,000 $670,700 1,000,451 -2.0%
2012-10-18 23:18 2012-10-16 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $34.25 20,000 $684,900 1,020,451 -1.9%
2012-10-15 23:27 2012-10-11 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $33.07 20,000 $661,400 1,040,451 -1.9%
2012-10-04 23:06 2012-10-02 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $33.71 20,000 $674,100 1,060,451 -1.9%
2012-10-01 23:06 2012-09-27 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $33.82 20,000 $676,300 1,079,711 -1.8%
2012-09-20 23:11 2012-09-18 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $32.98 20,000 $659,500 1,099,711 -1.8%
2012-08-15 23:09 2012-08-13 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director OPT+S $31.58 10,000 $315,800 1,269,711 0.0%
2012-08-13 23:42 2012-08-09 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $31.81 10,000 $318,050 879,711 -1.1%
2012-08-03 01:30 2012-08-01 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $34.33 10,000 $343,250 889,711 -1.1%
2012-07-26 23:48 2012-07-25 BMY BRISTOL MYERS SQUIBB CO Pharmaceutical Preparations Director SELL $35.29 10,000 $352,900 899,711 -1.1%
SHOW ENTRIES

Tracking Multi-Role Insiders: CORNELIUS JAMES M

High-level stakeholders like CORNELIUS JAMES M, whether acting as directors, officers, or 10% owners, often possess unique cross-sector insights. Monitoring a specific CIK like 0001198959 allows investors to identify recurring patterns of trading success across various industries. When a large 10% shareholder or a key beneficial owner moves capital, it often signals a strategic shift in institutional or private conviction.

SEC Transparency for Key Stakeholders

Every market move made by CORNELIUS JAMES M is a matter of public record under federal law. By aggregating Form 4 filings, we provide transparency into the portfolios of major players who hold significant influence. Following the money of those with a 10% stake or executive power helps bridge the information gap between the boardroom and the retail investor.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.